COMPASS Pathways plc(CMPS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CMPS COMPASS Pathways plc

盘后交易 06-17 17:11:41 EDT

11.94

+0.45

+3.92%

盘后11.86

-0.08-0.67%

17:01 EDT

最高12.33	最低11.51	成交量207.30万
今开11.59	昨收11.49	日振幅7.13%
总市值16.12亿	流通市值12.18亿	总股本1.35亿
成交额2,494万	换手率2.03%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":11.94,"timestamp":1781726400000,"preClose":11.49,"halted":0,"volume":2073003,"hourTrading":{"tag":"盘后","latestPrice":11.86,"preClose":11.94,"latestTime":"17:01 EDT","volume":21178,"amount":252753.097778,"timestamp":1781730061475,"change":-0.08,"changeRate":-0.0067,"amplitude":0.033501},"delay":0,"changeRate":0.03916449086161874,"floatShares":102000000,"shares":135000000,"eps":-3.080125,"marketStatus":"盘后交易","change":0.45,"latestTime":"06-17 17:11:41 EDT","open":11.59,"high":12.33,"low":11.5105,"amount":24939629.513031002,"amplitude":0.071323,"askPrice":12.2,"askSize":115,"bidPrice":11.86,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-3.080125,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1781740800000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":11.49,"preHourTrading":{"tag":"盘前","latestPrice":11.51,"preClose":11.49,"latestTime":"09:24 EDT","volume":14180,"amount":162898.71978,"timestamp":1781702641287,"change":0.02,"changeRate":0.001741,"amplitude":0.030331},"postHourTrading":{"tag":"盘后","latestPrice":11.86,"preClose":11.94,"latestTime":"17:01 EDT","volume":21178,"amount":252753.097778,"timestamp":1781730061475,"change":-0.08,"changeRate":-0.0067,"amplitude":0.033501},"volumeRatio":0.828834,"impliedVol":0.9939,"impliedVolPercentile":0.4104},"requestUrl":"/m/hq/s/CMPS","defaultTab":"news","newsList":[{"id":"1102269560","title":"COMPASS Pathways宣布FDA批准新药申请滚动审评请求并授予专员国家优先审评券","url":"https://stock-news.laohu8.com/highlight/detail?id=1102269560","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102269560?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:38","pubTimestamp":1777041494,"startTime":"0","endTime":"0","summary":"生物医药公司COMPASS Pathways plc宣布，美国食品药品监督管理局（FDA）已正式批准其新药申请（NDA）的滚动审评请求，同时授予专员国家优先审评券。这一重要进展将显著加速该公司创新疗法的审评进程。\n滚动审评机制允许制药企业分阶段提交NDA资料，而非一次性提交完整申请材料，有助于FDA更早介入审评流程。国家优先审评券的授予进一步体现了该疗法在解决未满足医疗需求方面的重要价值，将为后续审评提供优先通道。\n此次监管突破标志着COMPASS Pathways在精神健康领域创新药物研发取得实质性进展，为公司核心产品的商业化奠定重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628742200","title":"特朗普签署行政令加速PTSD疗法研发：美迷幻药物板块迎来“结构性拐点”，盘前全线飙升！","url":"https://stock-news.laohu8.com/highlight/detail?id=2628742200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628742200?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:23","pubTimestamp":1776684215,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在美国总统特朗普签署了一项旨在加速研究并扩大对用于治疗创伤后应激障碍的海外物质的获取渠道的行政令后，迷幻药物相关股票在盘前交易中上涨。投行奥本海默分析师杰伊·奥尔森表示，特朗普的行政令“通过促进研究、简化监管时间表和扩大患者获取渠道，代表了美国迷幻药物行业的一个结构性拐点，这强化了我们的积极展望”。报告指出，这是该领域取得的又一积极进展，利好 RBC 覆盖的迷幻药物公司：Definium Therapeutics、Compass Pathways 和 GH Research。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"88f7b346cf902c973ba59a5779bb445e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430797.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","LU0029864427.USD","CMPS","LU1267930573.SGD","BK4559","HELP","BK4007","LU0310800379.SGD","BK4127","BK4139","BK4009","BK4161","LU0708994859.HKD","GHRS","IE00B64QTZ34.USD","ATAI","BK4207","LU0128525929.USD","LU2065731478.USD","IE00BLDYK493.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1114958406","title":"COMPASS Pathways公司已就抗抑郁疗法Comp360向FDA启动滚动申报程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1114958406","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114958406?lang=zh_cn&edition=full","pubTime":"2026-04-19 04:17","pubTimestamp":1776543432,"startTime":"0","endTime":"0","summary":"COMPASS Pathways公司宣布，针对其创新疗法Comp360在治疗耐药性抑郁症领域的应用，已与美国食品药品监督管理局（FDA）展开滚动申报程序的合作。这一进展标志着该公司在精神健康治疗领域的研发迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130056728","title":"COMPASS Pathways推出美国资助计划，旨在建立批准后Comp360服务提供商培训体系","url":"https://stock-news.laohu8.com/highlight/detail?id=1130056728","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130056728?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:32","pubTimestamp":1776162733,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc近日宣布启动一项美国资助计划，该计划致力于构建针对Comp360治疗方案获批后的专业医疗服务提供者培训体系。此举旨在通过系统化培训提升医疗人员对创新疗法的专业应用能力，为患者提供更规范的医疗服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148114808","title":"COMPASS Pathways公司：截至2024年3月现金状况预计足以支撑运营支出及资本支出至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1148114808","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148114808?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:37","pubTimestamp":1774352236,"startTime":"0","endTime":"0","summary":"根据最新披露，COMPASS Pathways plc（简称CMPS）在2024年3月底的现金储备状况表现强劲，足以覆盖公司日常运营支出及未来资本开支需求，资金可持续性预计将延续至2028年。这一稳健的财务基础为公司在精神健康治疗领域的创新药物研发提供了有力支撑，同时也增强了市场对其长期发展战略的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166925495","title":"COMPASS Pathways股价盘前飙涨30% 旗下抑郁症药物在二期后期试验中达成主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1166925495","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166925495?lang=zh_cn&edition=full","pubTime":"2026-02-17 19:57","pubTimestamp":1771329457,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc（简称：COMPASS Pathways）股价在盘前交易中大幅上涨30%，此前该公司宣布其研发的抑郁症药物在第二项后期临床试验中成功达到主要研究终点。\n这一积极结果显著提振了投资者信心，推动该生物技术公司股价在开盘前交易时段强势上扬。临床试验的成功意味着COMPASS Pathways在抑郁症治疗领域的创新药物向获得监管批准迈出了关键一步。\n市场分析师指出，此次试验结果的突破性进展不仅验证了该药物的疗效，也为公司未来商业化前景注入了强劲动力。受此消息影响，医疗保健板块相关股票亦呈现跟涨态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102466641","title":"COMPASS Pathways成功达成第二项三期临床试验主要终点，评估Comp360裸盖菇素治疗难治性抑郁症疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1102466641","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102466641?lang=zh_cn&edition=full","pubTime":"2026-02-17 19:31","pubTimestamp":1771327897,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc（股票代码：CMPS）近日宣布，其针对难治性抑郁症治疗的创新疗法Comp360裸盖菇素，在第二项关键的三期临床试验中成功达到主要研究终点。这一突破性进展标志着该疗法在验证其安全性与有效性方面迈出了坚实一步，为全球数百万受难治性抑郁症困扰的患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603617479","title":"Compass Pathways Plc盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603617479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603617479?lang=zh_cn&edition=full","pubTime":"2026-01-14 04:00","pubTimestamp":1768334403,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日04时00分，Compass Pathways Plc股票出现波动，股价大幅上涨5.14%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为0.01%。其相关个股中，Option Care Health, Inc.、Enhabit, Inc.、Basel Medical Group Ltd涨幅较大，Newgenivf Group Limited、Park Dental Partners, Inc.、Option Care Health, Inc.较为活跃，换手率分别为13.75%、2.36%、2.32%，振幅较大的相关个股有Basel Medical Group Ltd、Newgenivf Group Limited、Airsculpt Technologies, Inc.，振幅分别为15.09%、14.53%、12.40%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家心理健康护理公司，致力于加快患者获得基于证据的心理健康创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114040003a4c00b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114040003a4c00b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190512083","title":"COMPASS Pathways plc与Hercules签署第三版贷款与担保协议修订","url":"https://stock-news.laohu8.com/highlight/detail?id=1190512083","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190512083?lang=zh_cn&edition=full","pubTime":"2026-01-07 19:39","pubTimestamp":1767785994,"startTime":"0","endTime":"0","summary":"1月5日，COMPASS Pathways plc宣布与Hercules Capital达成贷款与担保协议的第三次修订。此次修订旨在优化现有融资条款，增强公司资金运作的灵活性。作为一家专注于精神健康领域的创新疗法研发企业，COMPASS Pathways此次协议调整将为其核心项目提供更稳定的财务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107848172","title":"COMPASS Pathways与Radial达成战略合作，革新患者体验并探索COMP360潜在给药模式","url":"https://stock-news.laohu8.com/highlight/detail?id=1107848172","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107848172?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:31","pubTimestamp":1767699080,"startTime":"0","endTime":"0","summary":"COMPASS Pathways plc（以下简称COMPASS）近日宣布与Radial建立战略合作伙伴关系，旨在通过创新技术优化患者体验，并为COMP360（其研发的裸盖菇素疗法）的未来给药模式提供重要参考依据。此次合作将聚焦于开发数字化工具与支持平台，提升患者在接受精神健康治疗过程中的参与度与便利性。COMP360目前正处于临床研究阶段，用于治疗难治性抑郁症等精神类疾病。双方将通过数据整合与分析，探索更个性化、可扩展的医疗服务方案，为精神健康领域的治疗模式创新注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518775752","title":"Compass Pathways Plc盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518775752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518775752?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:14","pubTimestamp":1741616041,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时14分，Compass Pathways Plc股票出现异动，股价大幅下挫5.04%。截至发稿，该股报3.55美元/股，成交量21.0456万股，换手率0.23%，振幅6.66%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为2.80%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022140198a2a7d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022140198a2a7d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517162333","title":"Compass Pathways Plc2024财年实现净利润-1.55亿美元，同比减少30.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162333?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276864,"startTime":"0","endTime":"0","summary":"3月7日，Compass Pathways Plc公布财报，公告显示公司2024财年净利润为-1.55亿美元，同比减少30.25%；其中营业收入为0.00美元，每股基本收益为-2.30美元。从资产负债表来看，Compass Pathways Plc总负债58.97百万美元，其中短期债务7.24百万美元，资产负债比为0.04，流动比率为0.06。机构评级：截至2025年3月7日，当前有10家机构对Compass Pathways Plc目标价做出预测，其中目标均价为16.50美元，其中最低目标价为9.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000120a262a609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000120a262a609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517929763","title":"Compass Pathways Plc盘中异动 快速拉升5.06%报4.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517929763?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:59","pubTimestamp":1741208394,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时59分，Compass Pathways Plc股票出现波动，股价大幅上涨5.06%。截至发稿，该股报4.05美元/股，成交量75.022万股，换手率0.81%，振幅5.97%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为2.10%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045954abea1e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045954abea1e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517834849","title":"Compass Pathways Plc盘中异动 下午盘急速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517834849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517834849?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:02","pubTimestamp":1741118557,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时02分，Compass Pathways Plc股票出现波动，股价大幅上涨5.09%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为0.66%。其相关个股中，Kindly Md Inc C/Wts 31/05/2029 、Agilon Health, Inc.、Compass Pathways Plc涨幅较大，Newgenivf Group Limited、阿卡迪亚医疗保健、Imac Holdings, Inc.较为活跃，换手率分别为46.44%、2.94%、1.93%，振幅较大的相关个股有Newgenivf Group Limited C/Wts 03/04/2029、P3 Health Partners Inc C/Wts 19/11/2026 、The Oncology Institute, Inc.，振幅分别为47.60%、33.33%、24.24%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040237989bf7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040237989bf7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516465194","title":"Compass Pathways Plc盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516465194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516465194?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:43","pubTimestamp":1741023813,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时43分，Compass Pathways Plc股票出现波动，股价大幅下跌5.22%。截至发稿，该股报3.73美元/股，成交量38.7908万股，换手率0.42%，振幅9.16%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为0.95%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304014333abe66cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304014333abe66cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320403","title":"Compass Pathways Plc盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320403?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:38","pubTimestamp":1740753524,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时38分，Compass Pathways Plc股票出现波动，股价快速下跌5.10%。Compass Pathways Plc股票所在的医疗设施行业中，整体跌幅为4.08%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。消息层面，截至22时38分，《RBC：上半年有望迎来积极催化剂 COMPASS Pathways等12只中小型医药股值得一看》资讯为影响Compass Pathways Plc的重要信息。RBC予COMPASS Pathways“跑赢大盘”评级，目标价为15美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822384596341b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822384596341b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514858333","title":"Compass Pathways Plc盘中异动 股价大涨16.22%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514858333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514858333?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:30","pubTimestamp":1740666624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分，Compass Pathways Plc股票出现波动，股价快速拉升16.22%。Compass Pathways Plc股票所在的医疗设施行业中，整体涨幅为0.00%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。消息层面，截至22时30分，《RBC：上半年有望迎来积极催化剂 COMPASS Pathways等12只中小型医药股值得一看》资讯为影响Compass Pathways Plc的重要信息。RBC予COMPASS Pathways“跑赢大盘”评级，目标价为15美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223025a2567958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223025a2567958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191970159","title":"Compass Pathways 2024年第四季度GAAP每股收益$(0.63)低于预期$(0.62)，现金及等价物为1.651亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191970159","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191970159?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:36","pubTimestamp":1740656189,"startTime":"0","endTime":"0","summary":"Compass Pathways 报告其季度亏损为每股$，低于分析师共识预期的每股$，相差1.61%。与去年同期每股亏损$相比，这是一个18.87%的减少。以上内容来自Benzinga Earnings专栏，原文如下：Compass Pathways  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 1.61 percent. This is a 18.87 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Compass Pathways 2024年第四季度GAAP每股收益$(0.63)低于预期$(0.62)，现金及等价物为1.651亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514579198","title":"Compass Pathways Plc盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514579198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514579198?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:04","pubTimestamp":1740585895,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时04分，Compass Pathways Plc股票出现波动，股价大幅上涨5.07%。Compass Pathways Plc股票所在的医疗设施行业中，整体跌幅为2.20%。Compass Pathways Plc公司简介：Compass Pathways PLC是一家精神保健公司，致力于加快患者获得精神健康领域的循证创新。消息层面，截至00时04分，《RBC：上半年有望迎来积极催化剂 COMPASS Pathways等12只中小型医药股值得一看》资讯为影响Compass Pathways Plc的重要信息。RBC予COMPASS Pathways“跑赢大盘”评级，目标价为15美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000456abde034d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000456abde034d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514388313","title":"RBC：上半年有望迎来积极催化剂 COMPASS Pathways(CMPS.US)等12只中小型医药股值得一看","url":"https://stock-news.laohu8.com/highlight/detail?id=2514388313","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514388313?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:36","pubTimestamp":1740558962,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，RBC Capital Markets发布研报称，虽然投资者主要关注的是大型制药和生物技术公司的业绩，但该行认为，2025年第一季度中小市值生物技术公司的一些重要催化剂可能对其覆盖的股票产生重大影响。2018年，COMPASS获得了美国FDA授予的突破性疗法认定，用于治疗TRD。RBC预计，Cytokinetics在2025年上半年有着重要催化剂。RBC表示，基于最初32名患者的1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","09939","159938","BK4139","BK1574","CMPS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasspathways.com","stockEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":0.108},{"period":"3month","weight":0.9541},{"period":"6month","weight":0.8502},{"period":"1year","weight":1.4763},{"period":"ytd","weight":0.6652}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0151},{"period":"3month","weight":0.1344},{"period":"6month","weight":0.1092},{"period":"1year","weight":0.245},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"COMPASS Pathways plc最初于2020年6月根据英格兰和威尔士法律成立为一家私人有限公司。该公司是一家生物技术公司，致力于加速推动患者获得基于证据的精神健康创新疗法。该公司正在通过开发他们的研究性COMP360 psilocybin治疗，开创一种以快速和持久反应为重点的治疗心理健康状况的新范式，这可能是同类治疗中的首创。COMP360是他们专有的裸盖菇素制剂，其中包括他们的医药级多形结晶裸盖菇素，针对稳定性和纯度进行了优化。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053854},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.067409},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.124725},{"month":4,"riseRate":0.5,"avgChangeRate":0.092687},{"month":5,"riseRate":0.5,"avgChangeRate":0.037097},{"month":6,"riseRate":0.5,"avgChangeRate":-0.03515},{"month":7,"riseRate":0.8,"avgChangeRate":0.262657},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005792},{"month":9,"riseRate":0.2,"avgChangeRate":-0.10118},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.009194},{"month":11,"riseRate":0.333333,"avgChangeRate":0.034765},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01163}],"exchange":"NASDAQ","name":"COMPASS Pathways plc","nameEN":"COMPASS Pathways plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COMPASS Pathways plc(CMPS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供COMPASS Pathways plc(CMPS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"COMPASS Pathways plc,CMPS,COMPASS Pathways plc股票,COMPASS Pathways plc股票老虎,COMPASS Pathways plc股票老虎国际,COMPASS Pathways plc行情,COMPASS Pathways plc股票行情,COMPASS Pathways plc股价,COMPASS Pathways plc股市,COMPASS Pathways plc股票价格,COMPASS Pathways plc股票交易,COMPASS Pathways plc股票购买,COMPASS Pathways plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COMPASS Pathways plc(CMPS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供COMPASS Pathways plc(CMPS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}